Drug Application Partner
Quotient Sciences understand that getting molecules to proof-of-concept (POC) and new drug application (NDA) are key milestones in the development of a new drug candidate. That is why we offer our fully integrated capabilities including our unique Translational Pharmaceutics® platform to reach those milestones faster. From first-in-human testing to seamless drug product supply for patient trials and drug optimization, we operate a cost-effective process that accelerates molecules through key milestones, faster.
From your molecule discovery to proof-of-concept (POC) to New Drug Application (NDA), Quotient Sciences are well equipped to partner with you to accelerate your drug approval process and reach your key milestones.
We have over 30 years of success at simplifying the early development to proof-of-concept of molecules, a key milestone in the development of a new drug candidate. At the same time, we also understand the transition to POC & NDA needs to be fast and cost-effective.